Zdrowie i gospodarka · 28/11/1994
Adverse Experience Reporting Requirements for Human Drug and Licensed Biological Products; Correction
The Food and Drug Administration (FDA) is correcting a proposal that appeared in the Federal Register of October 27, 1994 (59 FR 54046). That document proposed to amend FDA's current adverse experience reporting regulations for human drugs and biological products. The document was published with two errors. This document corrects those errors.